Diabetes ranks among the top 10 causes of death globally and affects over half a billion people worldwide. Over 80% of those affected live in low- and middle-income countries (LMICs). Insulin pens and newer diabetes
Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali,
Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot Munich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for
Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported
The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn
As an international medical humanitarian organisation, Médecins Sans Frontières/Doctors Without Borders (MSF) has repeatedly witnessed how the world’s most vulnerable people are left without access to the lifesaving medicines, diagnostics tests and vaccines they need.
MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 – At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today,
With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles Geneva, 15 April 2024 – Ahead of
Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along
Geneva/New Delhi, 15 February 2024 — In a welcome move today, the Indian Commerce Ministry confirmed its rejection of Switzerland’s demand for data exclusivity for medicines in the India-EFTA trade deal, and emphasised the importance
Text leaked yesterday shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws. Geneva/New Delhi, 14 February 2024 — Following news that India and the European
endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union
Sign up for our emails and get deeper insight into world and work of MSF!
